HIGHLIGHTS
- who: Jong Hoon Lee and collaborators from the Science and Research Center, National University College of Medicine, Daehak-ro, Jongno-gu, Greenville, TX, USA have published the research work: COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs, in the Journal: (JOURNAL) of 21/Dec/2020
- what: This analysis showed a lower risk of death or discharge to long-term acute care hospitals (RR=0.52, 95% CI: 0.32 to 0.84) and a higher likelihood of discharge home (RR=2.7, 95% CI: 1.2 to 5.9) with dapsone compared with those receiving . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.